The post Benchmark Boosts Bitcoin Miner Maker Canaan’s Stock Target, Praising ‘Turnaround Story’ appeared on BitcoinEthereumNews.com. In brief Investment bank Benchmark on Thursday raised the price target for Nasdaq-listed Bitcoin mining machine manufacturer Canaan. The company’s stock is up this week. Benchmark analyst Mark Palmer says the firm’s stock now is a good buy. Investment bank Benchmark raised Bitcoin mining hardware manufacturer Canaan’s price target to $4, citing the firm’s recent compliance notification from Nasdaq Stock Market and demand for the company’s rigs.  The Nasdaq last week informed Canaan that it had reached the minimum bid price of $1 per share so would not be at risk of being delisted. Since October, the company’s stock has traded above that level. Equity research analyst Mark Palmer also said that Canaan’s Avalon line of Bitcoin mining rigs was gaining popularity.  “The company has steadily gained traction with these machines, appealing to miners seeking improved efficiency, reliability, and cost competitiveness,” he wrote.  He added: “We also believe yesterday’s broad selloff in crypto-related shares represents an attractive opportunity for investors to gain exposure to the company’s accelerating turnaround story through its very inexpensive stock, which trades at just 0.8x FY27E EV/sales.”  Palmer further added that the company’s strong balance sheet of 1,582 Bitcoins and 2,830 Ethereum—a combined total of over $186 million—was a “record,” and another reason for the price target.  Benchmark previously had given the Singapore-based company a price target of $2 per share.  Canaan’s stock traded 5.6% higher on Thursday; reaching $4 per share would mean it would have to jump about 118% from its current price of $1.80. Canaan’s share price has fallen nearly 19% year-to-date.  Miners, who earn Bitcoin for verifying transactions on the blockchain, have had to address rising costs and reduced rewards. Last year’s halving cut the amount of BTC miners could earn from 6.25 to 3.125. In this more challenging landscape, a… The post Benchmark Boosts Bitcoin Miner Maker Canaan’s Stock Target, Praising ‘Turnaround Story’ appeared on BitcoinEthereumNews.com. In brief Investment bank Benchmark on Thursday raised the price target for Nasdaq-listed Bitcoin mining machine manufacturer Canaan. The company’s stock is up this week. Benchmark analyst Mark Palmer says the firm’s stock now is a good buy. Investment bank Benchmark raised Bitcoin mining hardware manufacturer Canaan’s price target to $4, citing the firm’s recent compliance notification from Nasdaq Stock Market and demand for the company’s rigs.  The Nasdaq last week informed Canaan that it had reached the minimum bid price of $1 per share so would not be at risk of being delisted. Since October, the company’s stock has traded above that level. Equity research analyst Mark Palmer also said that Canaan’s Avalon line of Bitcoin mining rigs was gaining popularity.  “The company has steadily gained traction with these machines, appealing to miners seeking improved efficiency, reliability, and cost competitiveness,” he wrote.  He added: “We also believe yesterday’s broad selloff in crypto-related shares represents an attractive opportunity for investors to gain exposure to the company’s accelerating turnaround story through its very inexpensive stock, which trades at just 0.8x FY27E EV/sales.”  Palmer further added that the company’s strong balance sheet of 1,582 Bitcoins and 2,830 Ethereum—a combined total of over $186 million—was a “record,” and another reason for the price target.  Benchmark previously had given the Singapore-based company a price target of $2 per share.  Canaan’s stock traded 5.6% higher on Thursday; reaching $4 per share would mean it would have to jump about 118% from its current price of $1.80. Canaan’s share price has fallen nearly 19% year-to-date.  Miners, who earn Bitcoin for verifying transactions on the blockchain, have had to address rising costs and reduced rewards. Last year’s halving cut the amount of BTC miners could earn from 6.25 to 3.125. In this more challenging landscape, a…

Benchmark Boosts Bitcoin Miner Maker Canaan’s Stock Target, Praising ‘Turnaround Story’

For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

In brief

  • Investment bank Benchmark on Thursday raised the price target for Nasdaq-listed Bitcoin mining machine manufacturer Canaan.
  • The company’s stock is up this week.
  • Benchmark analyst Mark Palmer says the firm’s stock now is a good buy.

Investment bank Benchmark raised Bitcoin mining hardware manufacturer Canaan’s price target to $4, citing the firm’s recent compliance notification from Nasdaq Stock Market and demand for the company’s rigs. 

The Nasdaq last week informed Canaan that it had reached the minimum bid price of $1 per share so would not be at risk of being delisted. Since October, the company’s stock has traded above that level.

Equity research analyst Mark Palmer also said that Canaan’s Avalon line of Bitcoin mining rigs was gaining popularity. 

“The company has steadily gained traction with these machines, appealing to miners seeking improved efficiency, reliability, and cost competitiveness,” he wrote. 

He added: “We also believe yesterday’s broad selloff in crypto-related shares represents an attractive opportunity for investors to gain exposure to the company’s accelerating turnaround story through its very inexpensive stock, which trades at just 0.8x FY27E EV/sales.”

Palmer further added that the company’s strong balance sheet of 1,582 Bitcoins and 2,830 Ethereum—a combined total of over $186 million—was a “record,” and another reason for the price target. 

Benchmark previously had given the Singapore-based company a price target of $2 per share. 

Canaan’s stock traded 5.6% higher on Thursday; reaching $4 per share would mean it would have to jump about 118% from its current price of $1.80. Canaan’s share price has fallen nearly 19% year-to-date. 

Miners, who earn Bitcoin for verifying transactions on the blockchain, have had to address rising costs and reduced rewards. Last year’s halving cut the amount of BTC miners could earn from 6.25 to 3.125. In this more challenging landscape, a number of miners have begun focusing more on high performance computing that is integral to AI. 

Investors have viewed this trend positively. Google last month announced it was backstopping a deal between AI compute company Fluidstack and Bitcoin miner Cipher, giving Google the right to buy a 5.4% stake in Cipher.

Earlier this month, Canaan announced that it had landed its largest order in three years: more than 50,000 Avalon A15 Pro Bitcoin mining machines from an unnamed U.S. customer. The computers represent Canaan’s latest-gen mining hardware, designed to offer what the company described as industry-leading efficiency and reliability—critical factors as power costs increasingly determine mining profitability.

Bitcoin was recently trading at about $110,340, up 1.7% over the past 24 hours, although BTC has fallen more than 8% over the past month.

Daily Debrief Newsletter

Start every day with the top news stories right now, plus original features, a podcast, videos and more.

Source: https://decrypt.co/345720/benchmark-boosts-bitcoin-maker-canaans-stock-target-turnaround

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09